Literature DB >> 3619476

How should chylothorax be managed?

J W Puntis, K D Roberts, D Handy.   

Abstract

The management and complications of chylothorax occurring beyond the neonatal period were reviewed retrospectively. Records from 15 patients treated between 1976 and 1986 were analysed; a combination of thoracocentesis, chest drain insertion, and dietary modification were successful in abolishing chyle leakage in 10 cases. One child died from complications of cardiac surgery rather than from the chylothorax, and surgical intervention was necessary in the remaining four patients and included pleurectomy in three and thoracic duct ligation in the fourth. Lymphopenia, hypoalbuminaemia, hyponatraemia, and weight loss were the most common complications of conservative management and tended to occur in those patients with the longest duration of drainage. Postoperative recovery after pleurectomy and thoracic duct ligation was uneventful. We conclude that conservative management of chylothorax will be successful in most cases. Complications of such a policy are fairly common but rarely serious.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619476      PMCID: PMC1778454          DOI: 10.1136/adc.62.6.593

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  THE MANAGEMENT OF CHYLOTHORAX.

Authors:  K R WILLIAMS; T H BURFORD
Journal:  Ann Surg       Date:  1964-07       Impact factor: 12.969

2.  The effect of fluid, electrolyte and food intake on thoracic duct lymph flow in unanaesthetized rats.

Authors:  W J SIMMONDS
Journal:  Aust J Exp Biol Med Sci       Date:  1954-06

3.  Nutritional management of thoracic duct fistulas. A comparative study of parenteral versus enteral nutrition.

Authors:  W Ramos; J Faintuch
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Sep-Oct       Impact factor: 4.016

4.  Management of chylothorax in children by thoracentesis and medium-chain triglyceride feedings.

Authors:  A M Kosloske; L W Martin; W K Schubert
Journal:  J Pediatr Surg       Date:  1974-06       Impact factor: 2.545

Review 5.  Medium chain triglycerides in paediatric practice.

Authors:  M Gracey; V Burke; C M Anderson
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

6.  Chylothorax: indications for surgery.

Authors:  J G Selle; W H Snyder; J T Schreiber
Journal:  Ann Surg       Date:  1973-02       Impact factor: 12.969

7.  Chylothorax after surgery for congenital heart disease.

Authors:  C B Higgins; D G Mulder
Journal:  J Thorac Cardiovasc Surg       Date:  1971-03       Impact factor: 5.209

8.  Transient T-cell depression in postoperative chylothorax.

Authors:  B C McWilliams; L L Fan; S A Murphy
Journal:  J Pediatr       Date:  1981-10       Impact factor: 4.406

9.  Child abuse presenting as chylothorax.

Authors:  H G Green
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

  9 in total
  4 in total

Review 1.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

2.  Generalised lymphangiomatosis with chylothorax.

Authors:  H Dunkelman; N Sharief; L Berman; T Ninan
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

3.  Pulmonary hypertension as a rare cause of postoperative chylothorax.

Authors:  Feridoun Sabzi; Samsam Dabiri; Alireza Poormotaabed
Journal:  J Tehran Heart Cent       Date:  2014

4.  Lymphatic Endothelial Cell Defects in Congenital Cardiac Patients With Postoperative Chylothorax.

Authors:  Aqsa Shakoor; June K Wu; Ajit Muley; Christopher Kitajewski; Joseph D McCarron; Noa Shapiro-Franklin; Rozelle Corda; Sophia Chrisomalis-Dring; Paul J Chai; Carrie J Shawber
Journal:  J Vasc Anom (Phila)       Date:  2021-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.